How mycobacterium tuberculosis subverts host immune responses

BioEssays

Volumn 30, Issue 10, 2008, Pages 943-954

  Józefowski, Szczepan ^a   Sobota, Andrzej ^a   Kwiatkowska, Katarzyna ^a  

^a NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD209 ANTIGEN; CERAMIDE; INTERLEUKIN 10; INTERLEUKIN 12P40; LIPOARABINOMANNAN; NITRIC OXIDE; SPHINGOMYELIN PHOSPHODIESTERASE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; LIPOMANNAN; LIPOPOLYSACCHARIDE; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLINOSITOL MANNOSIDE;

ADAPTIVE IMMUNITY; ANTIINFLAMMATORY ACTIVITY; BACTERIAL CELL WALL; BACTERIAL GROWTH; BACTERIAL SURVIVAL; BACTERIAL TRANSMISSION; CELL MEMBRANE; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; INTERFERON PRODUCTION; LIPID RAFT; LUNG ALVEOLUS MACROPHAGE; LUNG TUBERCULOSIS; MACROPHAGE ACTIVATION; MOLECULAR MIMICRY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHAGOCYTOSIS; PHAGOSOME; REVIEW; SIGNAL TRANSDUCTION; TH2 CELL; ACYLATION; CELL WALL; DENDRITIC CELL; IMMUNOLOGY; MACROPHAGE; METABOLISM; MICROBIOLOGY; TH1 CELL;

CORYNEBACTERINEAE; MYCOBACTERIUM TUBERCULOSIS;

ACYLATION; CELL WALL; DENDRITIC CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; LIPOPOLYSACCHARIDES; MACROPHAGES; MEMBRANE MICRODOMAINS; MYCOBACTERIUM TUBERCULOSIS; PHOSPHATIDYLINOSITOLS; TH1 CELLS; TH2 CELLS; TUBERCULOSIS, PULMONARY;

EID: 53149117862     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/bies.20815     Document Type: Review

References (105)

1. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. 1999. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. W.H.O. Global Surveillance and Monitoring Project. JAMA 282:677-686.
2. Beatty WL, Rhoades ER, Ullrich HJ, Chatterjee D, Heuser JE, et al. 2000. Trafficking and release of mycobacterial lipids from infected macrophages. Traffic 1:235-247.
3. Chatterjee D, Lowell K, Rivoire B, McNeil MR, Brennan PJ. 1992. Lipoarabinomannan of Mycobacterium tuberculosis: capping with mannosyl residues in some strains. J Biol Chem 267:6234-6239.
4. Guérardel Y, Maes E, Briken V, Chirat F, Leroy Y, et al. 2003. Lipomannan and lipoarabinomannan from a clinical isolate of Mycobacterium kansasii: novel structural features and apoptosis-inducing properties. J Biol Chem 278:36637-36651.
5. Prinzis S, Chatterjee D, Brennan PJ. 1993. Structure and antigenicity of lipoarabinomannan from Mycobacterium bovis BCG. J Gen Microbiol 139:2649-2658.
6. Venisse A, Berjeaud JM, Chaurand P, Gilleron M, Puzo G. 1993. Structural features of lipoarabinomannan from Mycobacterium bovis BCG: determination of molecular mass by laser desorption mass spectrometry. J Biol Chem 268:12401-12411.
7. Khoo KH, Tang JB, Chatterjee D. 2001. Variation in mannose-capped terminal arabinan motifs of lipoarabinomannans from clinical isolates of Mycobacterium tuberculosis and Mycobacterium avium complex. J Biol Chem 276:3863-3871.
8. Gilleron M, Himoudi N, Adam O, Constant P, Venisse A, et al. 1997. Mycobacterium smegmatis phosphoinositols-glyceroarabinomannans: structure and localization of alkali-labile and alkali-stable phosphoinositides. J Biol Chem 272:117-124.
9. Khoo KH, Dell A, Morris HR, Brennan PJ, Chatterjee D. 1995. Inositol phosphate capping of the nonreducing termini of lipoarabinomannan from rapidly growing strains of Mycobacterium. J Biol Chem 270:12380-12389.
10. Guérardel Y, Maes E, Elass E, Leroy Y, Timmerman P, et al. 2002. Structural study of lipomannan and lipoarabinomannan from Mycobacterium chelonae: presence of unusual components with α1,3-mannopyranose side chain. J Biol Chem 277:30635-30648.
11. Medzhitov R, Janeway CA Jr. 2002. Decoding the patterns of self and nonself by the innate immune system. Science 296:298-300.
12. O'Neill LA, Bowie AG. 2007. The family of five: TIR-domain-containing adaptors in Toll-like receptor signaling. Nat Rev Immunol 7:353-364.
13. Means TK, Lien E, Yoshimura A, Wang S, Golenbock DT, et al. 1999. The CD14 ligands lipoarabinomannan and lipopolysaccharide differ in their requirement for Toll-like receptors. J Immunol 163:6748-6755.
14. Jung YJ, LaCourse R, Ryan L, North RJ. 2002. Virulent but not avirulent Mycobacterium tuberculosis can evade the growth inhibitory action of a T helper 1-dependent, nitric oxide Synthase 2-independent defense in mice. J Exp Med 196:991-998.
15. Gutierrez MG, Master SS, Singh SB, Taylor GA, Colombo MI, et al. 2004. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 119:753-766.
16. Abel B, Thieblemont N, Quesniaux VJ, Brown N, Mpagi J, et al. 2002. Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice. J Immunol 169:3155-3162.
17. Drennan MB, Nicolle D, Quesniaux VJ, Jacobs M, Allic N, et al. 2004. Toll-like receptor 2-deficient mice succumb to Mycobacterium tuberculosis infection. Am J Pathol 164:49-57.
18. Reiling N, Holscher C, Fehrenbach A, Kroger S, Kirschning CJ, et al. 2002. Cutting edge: Toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis. J Immunol 169:3480-3484.
19. Nicolle D, Fremond C, Pichon X, Bouchot A, Maillet I, et al. 2004. Longterm control of Mycobacterium bovis BCG infection in the absence of Toll-like receptors (TLRs): investigation of TLR2-, TLR6-, or TLR2-TLR4-deficient mice. Infect Immun 72:6994-7004.
20. Gautier G, Humbert M, Deauvieau F, Scuiller M, Hiscott J, et al. 2005. A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells. J Exp Med 201:1435-1446.
21. Dillon S, Agrawal A, Van Dyke T, Landreth G, McCauley L, et al. 2004. A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells. J Immunol 172:4733-4743.
22. Pulendran B, Kumar P, Cutler CW, Mohamadzadeh M, Van Dyke T, et al. 2001. Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo. J Immunol 167:5067-5076.
23. Re F, Strominger JL. 2004. IL-10 released by concomitant TLR2 stimulation blocks the induction of a subset of Th1 cytokines that are specifically induced by TLR4 or TLR3 in human dendritic cells. J Immunol 173:7548-7555.
24. Means TK, Wang S, Lien E, Yoshimura A, Golenbock DT, et al. 1999. Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J Immunol 163:3920-3927.
25. Vignal C, Guéraldel Y, Kremer L, Masson M, Legrand D, et al. 2003. Lipomannans, but not lipoarabinomannans, purified from Mycobacterium chelonae and Mycobacterium kansasii induce TNF-α and IL-8 secretion by a CD14-Tool-like receptor 2-dependent mechanism. J Immunol 171:2014-2023.
26. Dao DN, Kremer L, Gue'rardel Y, Molano A, Jacobs WR Jr, et al. 2004. Mycobacterium tuberculosis lipomannan induces apoptosis and interleukin-12 production in macrophages. Infect Immun 72:2067-2074.
27. Quesniaux VJ, Nicole DM, Torres D, Kremer L, Guéraldel Y, et al. 2004. Toll-like receptor 2 (TLR2)-dependent-positive and TLR2-independent-negative regulation of proinflammatory cytokines by mycobacterial lipomannans. J Immunol 172:4425-4434.
28. Flynn JL, Goldstein MM, Chan J, Triebold KJ, Pfeffer K, et al. 1995. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2: 561-572.
29. Balcewicz-Sablinska MK, Keane J, Kornfeld H, Remold HG. 1998. Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation of TNF-alpha. J Immunol 161:2636-2641.
30. Basu S, Pathak SK, Banerjee A, Pathak S, Bhattacharyya A, et al. 2007. Execution of macrophage apoptosis by PE_PGRS33 of Mycobacterium tuberculosis is mediated by Toll-like receptor 2-dependent release of tumor necrosis factor-alpha. J Biol Chem 282:1039-1050.
31. Molloy A, Laochumroonvorapong P, Kaplan G. 1994. Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guérin. J Exp Med 180:1499-1509.
32. Schaible UE, Winau F, Sieling PA, Fischer K, Collins HL, et al. 2003. Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis. Nat Med 9:1039-1046.
33. Arko-Mensah J, Julián E, Singh M, Fernández C. 2007. TLR2 but not TLR4 signalling is critically involved in the inhibition of IFN-gamma-induced killing of mycobacteria by murine macrophages. Scand J Immunol 65:148-157.
34. Banaiee N, Kincaid EZ, Buchwald U, Jacobs WR Jr, Ernst JD. 2006. Potent inhibition of macrophage responses to IFN-gamma by live virulent Mycobacterium tuberculosis is independent of mature mycobacterial lipoproteins but dependent on TLR2. J Immunol 176:3019-3027.
35. Bafica A, Scanga CA, Feng CG, Leifer C, Cheever A, et al. 2005. TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis. J Exp Med 202:1715-1724.
36. McConville MJ, Ferguson MA. 1993. The structure, biosynthesis and function of glycosylated phosphatidylinositols in the parasitic protozoa and higher eukaryotes. Biochem J 294:306-324.
37. Gilleron M, Quesniaux VF, Puzo G. 2003. Acylation state of the phosphatidylinositol hexamannosides from Mycobacterium bovis bacillus Calmette Guerin and mycobacterium tuberculosis H37Rv and its implication in Toll-like receptor response. J Biol Chem 278:29880-29889.
38. Fujita M, Jigami Y. 2008. Lipid remodeling of GPI-anchored proteins and its function. Biochim Biophys Acta 1780:410-420.
39. Schenkman S, Yoshida N, Cardoso de Almeida ML. 1988. Glycophosphatidylinositol-anchored proteins in metacyclic trypomastigotes of Trypanosoma cruzi. Mol Biochem Parasitol 29:141-151.
40. Pearce EJ, Sher A. 1989. Three major surface antigens of Schistosoma mansoni are linked to the membrane by glycosylphosphatidylinositol. J Immunol 142:979-984.
41. de Veer MJ, Curtis JM, Baldwin TM, DiDonato A Sexton A, et al. 2003. MyD88 is essential for clearance of Leishmania major: possible role for lipophosphoglycan and Toll-like receptor 2 signaling. Eur J Immunol 33:2822-2831.
42. Krishnegowda G, Hajjar AM, Zhu J, Douglass EJ, Uematsu S, et al. 2005. Induction of proinflammatory responses in macrophages by the glycosylphosphatidylinositols of Plasmodium falciparum: cell signaling receptors, glycosylphosphatidylinositol (GPI) structural requirement, and regulation of GPI activity. J Biol Chem 280:8606-8616.
43. Doz E, Rose S, Nigou J, Gilleron M, Puzo G, et al. 2007. Acylation determines the TLR-dependent positive versus TLR2-, mannose receptor- and SIGNR1-independent negative regulation of proinflammatory cytokines by mycobacterial lipomannan. J Biol Chem 36:26014-26025.
44. Elass E, Coddeville B, Guérardel Y, Kremer L, Maes E, et al. 2007. Identification by surface plasmon resonance of the mycobacterial lipomannan and lipoarabinomannan domains involved in binding to CD14 and LPS-binding protein. FEBS Lett 581:1383-1390.
45. Gilleron M, Nigou J, Nicolle D, Quesniaux V, Puzo G. 2006. The acylation state of mycobacterial lipomannans modulates innate immunity response through Toll-like receptor 2. Chem Biol 13:39-47.
46. Nigou J, Vasseldh T, Ray A, Constant P, Gilleron M, et al. 2008. Mannan chain length controls lipoglycans signaling via and binding to TLR2. J Immunol 180:6696-6702.
47. Zimmerli S, Edwards S, Ernst JD. 1996. Selective receptor blockade during phagocytosis does not alter the survival and growth of Mycobacterium tuberculosis in human macrophages. Am J Respir Cell Mol Biol 15:760-770.
48. Tailleux L, Schwartz O, Herrmann J-L, Pivert E, Jackson M, et al. 2003. DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells. J Exp Med 197:121-127.
49. Beharka AA, Gaynor CD, Kang BK, Voelker DR, McCormack FX, et al. 2002. Pulmonary surfactant protein A up-regulates activity of the mannose receptor, a pattern recognition receptor expressed on human macrophages. J Immunol 169:3565-3573.
50. Kudo K, Sano H, Takahashi H, Kuronuma K, Yokota S, et al. 2004. Pulmonary collectins enhance phagocytosis of Mycobacterium avium through increased activity of mannose receptor. J Immunol 172:7592-7602.
51. Geijtenbeek TBH, van Vliet SJ, Koppel EA, Sanchez-Hernandez M, Vandenbroucke-Grauls CMJE, et al. 2003. Mycobacteria target DC-SIGN to suppress dendritic cell function. J Exp Med 197:7-17.
52. Schlesinger LS, Hull SR, Kaufman TM. 1994. Binding of the terminal mannosyl units of lipoarabinomannan from a virulent strain of Mycobacterium tuberculosis to human macrophages. J Immunol 152:4070-4079.
53. Schlesinger LS, Kaufman TM, Iyer S, Hull SR, Marchiando LK. 1996. Differences in mannose receptor-mediated uptake of lipoarabinomannan from virulent and attenuated strains of Mycobacterium tuberculosis by human macrophages. J Immunol 157:4568-4575.
54. Maeda N, Nigou J, Herrmann JL, Jackson M, Amara A, et al. 2003. The cell surface receptor DC-SIGN discriminates between Mycobacterium species through selective recognition of the mannose caps on lipoarabinomannan. J Biol Chem 278:5513-5516.
55. Appelmelk BJ, den Dunnen J, Driessen NN, Ummels R, Pak M, et al. 2008. The mannose cap of mycobacterial lipoarabinomannan does not dominate the Mycobacterium-host interaction. Cell Microbiol 10:930-944.
56. Rivière M, Moisand A, Lopez A, Puzo G. 2004. Highly ordered supra-molecular organization of the mycobacterial lipoarabinomannans in solution. Evidence of a relationship between supra-molecular organization and biological activity. J Mol Biol 344:907-918.
57. Marth T, Kelsall BL. 1997. Regulation of interleukin-12 by complement receptor 3 signaling. J Exp Med 185:1987-1995.
58. Nigou J, Zelle-Rieser C, Gilleron M, Thurnher M, Puzo G. 2001. Mannosylated lipoarabinomannans inhibit IL-12 production by human dendritic cells: evidence for a negative signal delivered through the mannose receptor. J Immunol 166:7477-7485.
59. 2 production and suppression of IL-12 release in murine macrophages. J Leukoc Biol 76:1066-1074.
60. Hussain S, Wright JR, Martin WJ 2nd. 2003. Surfactant protein A decreases nitric oxide production by macrophages in a tumor necrosis factor-alpha-dependent mechanism. Am J Respir Cell Mol Biol 28:520-527.
61. Allavena P, Chieppa M, Monti P, Piemonti L. 2004. From pattern recognition receptor to regulator of homeostasis: the doublefaced macrophage mannose receptor. Crit Rev Immunol 24:179-192.
62. Napper CE, Drickamer K, Taylor ME. 2006. Collagen binding by the mannose receptor mediated through the fibronectin type II domain. Biochem J 395:579-586.
63. Taylor ME, Bezouska K, Drickamer K. 1992. Contribution to ligand binding by multiple carbohydrate-recognition domains in the macrophages mannose receptor. J Biol Chem 267:1719-1726.
64. Weis WI, Drickamer K. 1994. Trimeric structure of a C-type mannosebinding protein. Structure 2:1227-1240.
65. Feinberg H, Mitchell DA, Drickamer K, Weis WI. 2001. Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR. Science 294:2163-2166.
66. Mitchell DA, Fadden AJ, Drickamer K. 2001. A novel mechanism of carbohydrate recognition by the C-type lectins DC-SIGN and DC-SIGNR. Subunit organization and binding to multivalent ligands. J Biol Chem 276:28939-28945.
67. Koppel EA, Ludwig IS, Hernandez MS, Lowry TL, Gadikota RR, et al. 2004. Identification of the mycobacterial carbohydrate structure that binds the C-type lectins DC-SIGN, L-SIGN and SIGNR1. Immunobiology 209:117-127.
68. Deretic V, Singh S, Master S, Harris J, Roberts E, et al. 2006. Mycobacterium tuberculosis inhibition of phagolysosome biogenesis and autophagy as a host defence mechanism. Cell Microbiol 8:719-727.
69. Kang PB, Azad AK, Torrelles JB, Kaufman TM, Beharka A, et al. 2005. The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesis. J Exp Med 202:987-999.
70. Pompei L, Jang S, Zamlynny B, Ravikumar S, McBride A, et al. 2007. Disparity in IL-12 release in dendritic cells and macrophages in response to Mycobacterium tuberculosis is due to use of distinct TLRs. J Immunol 178:5192-5199.
71. Sidobre S, Nigou J, Puzo G, Rivière M. 2000. Lipoglycans are putative ligands for the human pulmonary surfactant protein A attachment to mycobacteria. Critical role of the lipids for lectin-carbohydrate recognition. J Biol Chem 275:2415-2422.
72. Garg A, Barnes PF, Roy S, Quiroga MF, Wu S, et al. 2008. Mannosecapped lipoarabinomannan- and prostaglandin E2-dependent expansion of regulatory T cells in human Mycobacterium tuberculosis infection. Eur J Immunol 38:459-469.
73. Simons K, Vaz WL. 2004. Model systems, lipid rafts, and cell membranes. Annu Rev Biophys Biomol Struct 33:269-295.
74. Garner AE, Smith DA, Hooper NM. 2007. Sphingomyelin chain length influences the distribution of GPI-anchored proteins in rafts in supported lipid bilayers. Mol Membr Biol 24:233-242.
75. Razani B, Woodman SE, Lisanti MP. 2002. Caveolae: from cell biology to animal physiology. Pharmacol Rev 54:431-467.
76. Horejsí V. 2003. The roles of membrane microdomains (rafts) in T cell activation. Immunol Rev 191:148-164.
77. Holowka D, Gosse JA, Hammond AT, Han X, Sengupta P, et al. 2005. Lipid segregation and IgE receptor signaling: a decade of progress. Biochim Biophys Acta 1746:252-259.
78. Kwiatkowska K, Frey J, Sobota A. 2003. Phosphorylation of FcγRIIA is required for the receptor-induced actin rearrangement and capping: the role of membrane rafts. J Cell Sci 2003(116) 537-550.
79. Wang PY, Kitchens RL, Munford RS. 1995-1996. Bacterial lipopolysaccharide binds to CD14 in low-density domains of the monocytemacrophage plasma membrane. J Inflamm 47:126-137.
80. Miller SI, Ernst RK, Bader MW. 2005. LPS, TLR4 and infectious disease diversity. Nat Rev Microbiol 3:36-46.
81. Yu W, Soprana E, Cosentino G, Volta M, Lichenstein HS, et al. 1998. Soluble CD14(1-152) confers responsiveness to both lipoarabinomannan and lipopolysaccharide in a novel HL-60 cell bioassay. J Immunol 161:4244-4251.
82. Orr SL, Tobias P. 2000. LPS and LAM activation of the U373 astrocytoma cell line: differential requirement for CD14. J Endotoxin Res 6:215-222.
83. Jerala L. 2007. Structural biology of the LPS recognition. Int J Med Microbiol 297:353-363.
84. Jin MS, Kim SE, Heo JY, Lee ME, Kim HM, et al. 2007. Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell 130:1071-1082.
85. Kabouridis PS. 2006. Lipid rafts in T cell receptor signalling. Mol Membr Biol 23:49-57.
86. García-García E, Brown EJ, Rosales C. 2007. Transmembrane mutations to FcγRIIA alter its association with lipid rafts: implications for receptor signaling. J Immunol 178:3048-3058.
87. Pfeiffer A, Böttcher A, Orsó E, Kapinsky M, Nagy P, et al. 2001. Lipopolysaccharide and ceramide docking to CD14 provokes ligandspecific receptor clustering in rafts. Eur J Immunol 31:3153-3164.
88. Triantafilou M, Brandenburg K, Kusumoto S, Fukase K, Mackie A, et al. 2004. Combinational clustering of receptors following stimulation by bacterial products determines lipopolysaccharide responses. Biochem J 381:527-536.
89. Triantafilou M, Gamper FGJ, Haston RM, Mouratis MA, Morath S, et al. 2006. Membrane sorting of Toll-like receptor (TLR)-2/6 and TLR2/1 heterodimers at the cell surface determines heterotypic associations with CD36 and intracellular targeting. J Biol Chem 281:31002-31011.
90. Riethmüller J, Riehle A, Grassmée H, Gulbins E. 2006. Membrane rafts in host-pathogen interactions. Biochim Biophys Acta 1758:2139-2147.
91. Grassmá H, Schwarz H, Gulbins E. 2001. Molecular mechanisms of ceramide-mediated CD95 clustering. Biochem Biophys Res Commun 284:1016-1030.
92. Grassmé H, Riehle A, Wilker B, Gulbins E. 2005. Rhinoviruses infect human epithelial cells via ceramide-enriched membrane platforms. J Biol Chem 280:26256-26262.
93. Abdel Shakor AB, Kwiatkowska K, Sobota A. 2004. Cell surface ceramide generation precedes and controls FcγRII clustering and phosphorylation in rafts. J Biol Chem 279:36778-36787.
94. Grassmé H, Jendrossek V, Bock J, Riehle A, Gulbins E. 2002. Ceramide-rich membrane rafts mediate CD40 clustering. J Immunol 168:298-307.
95. Nurminen TA, Holopainen JM, Zhao H, Kinnunen PK. 2002. Observation of topical catalysis by sphingomyelinase coupled to microspheres. J Am Chem Soc 124:12129-12134.
96. MacKichan ML, DeFranco AL. 1999. Role of ceramide in lipopolysaccharide (LPS)-induced signaling. LPS increases ceramide rather than acting as a structural homolog. J Biol Chem 274:1767-1775.
97. Cuschieri J, Bulger E, Billgren J, Garcia I, Maier RV. 2007. Acid sphingomyelinase is required for lipid raft TLR4 complex formation. Surg Infect 8:91-105.
98. Sakata A, Ochiai T, Shimeno H, Hikishima S, Yokomatsu T, et al. 2007. Acid sphingomyelinase inhibition suppresses lipopolysaccharide-mediated release of inflammatory cytokines from macrophages and protects against disease pathology in dextran sulphate sodium-induced colitis in mice. Immunology 122:54-64.
99. Fischer H, Ellstrom P, Ekstrom K, Gustafsson L, Gustafsson M, et al. 2007. Ceramide as a TLR4 agonist; a putative signaling intermediate between sphingolipid receptors for microbal ligands and TLR4. Cell Microbiol 9:1239-1251.
100. Cuschieri J, Billgren J, Maier RV. 2006. Phosphatidylcholine-specific phospholipase C (PC-PLC) is required for LPS-mediated macrophage activation through CD14. J Leukoc Biol 80:407-414.
101. Edidin M. 2003. The state of lipid rafts: from model membranes to cells. Annu Rev Biophys Biomol Struct 32:257-283.
102. Shabaana AK, Kulangara K, Semac I, Parel Y, Ilangumaran S, et al. 2005. Mycobacterial lipoarabinomannans modulate cytokine production in human T helper cells by interfering with raft/microdomain signaling. Cell Mol Life Sci 62:179-187.
103. Ilangumaran S, Arni S, Poincelet M, Theler J-M, Brennan PJ, et al. 1995. Integration of mycobacterial lipoarabinomannans into glycosylphosphatidylinositol-rich domains of lymphomonocytic cell plasma membranes. J Immunol 155:1334-1342.
104. Astarie-Dequeker C, Nigou J, Puzo G, Maridonneau-Parini I. 2000. Lipoarabinomannans activate the protein tyrosine kinase Hck in human neutrophils. Infect Immun 68:4827-4830.
105. Hayakawa E, Tokumasu F, Nardone GA, Jin AJ, Hackley VA, et al. 2007. A Mycobacterium tuberculosis-derived lipid inhibits membrane fusion by modulating lipid membrane domains. Biophys J 93:4018-4030.